Literature DB >> 12152913

Screening and prevention of chronic kidney disease.

Errol D Crook1, David O Washington, John M Flack.   

Abstract

The burden of kidney disease is disproportionately high in African Americans, and the condition often remains undiagnosed until late-stage disease. In order to reduce this burden, strategies must be implemented to improve the detection of kidney disease, and preventative measures must be targeted at those at greatest risk of disease. Important risk factors among African Americans in the US include hypertension, diabetes, and obesity. In this review, we discuss screening strategies that will allow earlier detection of kidney disease. The sensitivity of serum creatinine, proteinuria, and microalbuminuria as markers of disease are discussed, as is the importance of calculating glomerular filtration rates in individual patients. Implementation of community-based programs, such as the Kidney Early Evaluation Program developed by the National Kidney Foundation, can offer screening for kidney disease and its risk factors, and can educate and protect African Americans at risk of this prevalent disease.

Entities:  

Mesh:

Year:  2002        PMID: 12152913      PMCID: PMC2594167     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  33 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines.

Authors:  W M McClellan; D F Knight; H Karp; W W Brown
Journal:  Am J Kidney Dis       Date:  1997-03       Impact factor: 8.860

3.  Renal disease in hypertensive adults: effect of race and type II diabetes mellitus.

Authors:  W M Tierney; C J McDonald; F C Luft
Journal:  Am J Kidney Dis       Date:  1989-06       Impact factor: 8.860

4.  Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications.

Authors:  R Pontremoli; A Sofia; M Ravera; C Nicolella; F Viazzi; A Tirotta; N Ruello; C Tomolillo; C Castello; G Grillo; G Sacchi; G Deferrari
Journal:  Hypertension       Date:  1997-11       Impact factor: 10.190

5.  Racial differences in the prevalence of microalbuminuria in hypertension.

Authors:  J H Summerson; R A Bell; J C Konen
Journal:  Am J Kidney Dis       Date:  1995-10       Impact factor: 8.860

6.  Renal insufficiency in treated essential hypertension.

Authors:  S G Rostand; G Brown; K A Kirk; E A Rutsky; H P Dustan
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

7.  The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.

Authors:  F L Brancati; J C Whittle; P K Whelton; A J Seidler; M J Klag
Journal:  JAMA       Date:  1992-12-02       Impact factor: 56.272

8.  Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease.

Authors:  S Bergman; B O Key; K A Kirk; D G Warnock; S G Rostant
Journal:  Am J Kidney Dis       Date:  1996-03       Impact factor: 8.860

9.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; A S Levey; G J Beck; A W Caggiula; L Hunsicker; J W Kusek; G Striker
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

10.  Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus.

Authors:  B I Freedman; A B Tuttle; B J Spray
Journal:  Am J Kidney Dis       Date:  1995-05       Impact factor: 8.860

View more
  2 in total

1.  Your Path to Transplant: a randomized controlled trial of a tailored computer education intervention to increase living donor kidney transplant.

Authors:  Amy D Waterman; Mark L Robbins; Andrea L Paiva; John D Peipert; Crystal S Kynard-Amerson; Christina J Goalby; LaShara A Davis; Jessica L Thein; Emily A Schenk; Kari A Baldwin; Stacy L Skelton; Nicole R Amoyal; Leslie A Brick
Journal:  BMC Nephrol       Date:  2014-10-14       Impact factor: 2.388

2.  Gene therapy by electroporation for the treatment of chronic renal failure in companion animals.

Authors:  Patricia A Brown; Angela M Bodles-Brakhop; Melissa A Pope; Ruxandra Draghia-Akli
Journal:  BMC Biotechnol       Date:  2009-01-16       Impact factor: 2.563

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.